307 related articles for article (PubMed ID: 37908729)
1. Theranostics with photodynamic therapy for personalized medicine: to see and to treat.
Wang Y; Staudinger JN; Mindt TL; Gasser G
Theranostics; 2023; 13(15):5501-5544. PubMed ID: 37908729
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer.
Sarbadhikary P; George BP; Abrahamse H
Theranostics; 2021; 11(18):9054-9088. PubMed ID: 34522227
[TBL] [Abstract][Full Text] [Related]
3. Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.
Sandland J; Malatesti N; Boyle R
Photodiagnosis Photodyn Ther; 2018 Sep; 23():281-294. PubMed ID: 30009949
[TBL] [Abstract][Full Text] [Related]
4. Redox-responsive dextran based theranostic nanoparticles for near-infrared/magnetic resonance imaging and magnetically targeted photodynamic therapy.
Ding Z; Liu P; Hu D; Sheng Z; Yi H; Gao G; Wu Y; Zhang P; Ling S; Cai L
Biomater Sci; 2017 Mar; 5(4):762-771. PubMed ID: 28256661
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast activation protein α activatable theranostic pro-photosensitizer for accurate tumor imaging and highly-specific photodynamic therapy.
Luo Y; Zeng Z; Shan T; Xu X; Chen J; He Y; Zhang T; Huang Z; Chai G; Huang Y; Zhao Y; Zhao C
Theranostics; 2022; 12(8):3610-3627. PubMed ID: 35664057
[TBL] [Abstract][Full Text] [Related]
6. Triple-Jump Photodynamic Theranostics: MnO
Wang Y; Li Y; Zhang Z; Wang L; Wang D; Tang BZ
Adv Mater; 2021 Oct; 33(41):e2103748. PubMed ID: 34423484
[TBL] [Abstract][Full Text] [Related]
7. Novel YOF-Based Theranostic Agents with a Cascade Effect for NIR-II Fluorescence Imaging and Synergistic Starvation/Photodynamic Therapy of Orthotopic Gliomas.
Lv Z; Jin L; Gao W; Cao Y; Zhang H; Xue D; Yin N; Zhang T; Wang Y; Zhang H
ACS Appl Mater Interfaces; 2022 Jul; 14(27):30523-30532. PubMed ID: 35775188
[TBL] [Abstract][Full Text] [Related]
8. A dual-targeted theranostic photosensitizer based on a TADF fluorescein derivative.
Liu Z; Shi W; Hong G; Chen W; Song B; Peng X; Xiong X; Song F
J Control Release; 2019 Sep; 310():1-10. PubMed ID: 31381942
[TBL] [Abstract][Full Text] [Related]
9. A Porphyrin Dimer-GdDOTA Conjugate as a Theranostic Agent for One- and Two-Photon Photodynamic Therapy and MRI.
Schmitt J; Jenni S; Sour A; Heitz V; Bolze F; Pallier A; Bonnet CS; Tóth É; Ventura B
Bioconjug Chem; 2018 Nov; 29(11):3726-3738. PubMed ID: 30252449
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer.
Wang Y; Jiang L; Zhang Y; Lu Y; Li J; Wang H; Yao D; Wang D
ACS Appl Mater Interfaces; 2020 Jul; 12(30):33564-33574. PubMed ID: 32633941
[TBL] [Abstract][Full Text] [Related]
11. A biomimetic theranostic O
Li SY; Xie BR; Cheng H; Li CX; Zhang MK; Qiu WX; Liu WL; Wang XS; Zhang XZ
Biomaterials; 2018 Jan; 151():1-12. PubMed ID: 29040939
[TBL] [Abstract][Full Text] [Related]
12. A PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer Theranostics.
Cui L; Lin Q; Jin CS; Jiang W; Huang H; Ding L; Muhanna N; Irish JC; Wang F; Chen J; Zheng G
ACS Nano; 2015; 9(4):4484-95. PubMed ID: 25830219
[TBL] [Abstract][Full Text] [Related]
13. An NIR-II-Emissive Photosensitizer for Hypoxia-Tolerant Photodynamic Theranostics.
Li L; Shao C; Liu T; Chao Z; Chen H; Xiao F; He H; Wei Z; Zhu Y; Wang H; Zhang X; Wen Y; Yang B; He F; Tian L
Adv Mater; 2020 Nov; 32(45):e2003471. PubMed ID: 33029855
[TBL] [Abstract][Full Text] [Related]
14. Folic Acid Functionalized Chlorin e6-Superparamagnetic Iron Oxide Nanocarriers as a Theranostic Agent for MRI-Guided Photodynamic Therapy.
Sun Z; Luo M; Li J; Wang A; Sun X; Wu Q; Li K; Ma Y; Yang C; Li X
J Biomed Nanotechnol; 2021 Feb; 17(2):205-215. PubMed ID: 33785092
[TBL] [Abstract][Full Text] [Related]
15. Three in One:
Boumati S; Sour A; Heitz V; Seguin J; Beitz G; Kaga Y; Jakubaszek M; Karges J; Gasser G; Mignet N; Doan BT
ACS Appl Bio Mater; 2023 Nov; 6(11):4791-4804. PubMed ID: 37862269
[TBL] [Abstract][Full Text] [Related]
16. 808 nm-excited upconversion nanoprobes with low heating effect for targeted magnetic resonance imaging and high-efficacy photodynamic therapy in HER2-overexpressed breast cancer.
Zeng L; Pan Y; Zou R; Zhang J; Tian Y; Teng Z; Wang S; Ren W; Xiao X; Zhang J; Zhang L; Li A; Lu G; Wu A
Biomaterials; 2016 Oct; 103():116-127. PubMed ID: 27376560
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-Potentiated Photodynamic Theranostics for Synergistic Tumor Ablation and Precise Anticancer Efficacy Monitoring.
Wang X; Tong J; He Z; Yang X; Meng F; Liang H; Zhang X; Luo L
ACS Appl Mater Interfaces; 2020 Feb; 12(5):5476-5487. PubMed ID: 31910619
[TBL] [Abstract][Full Text] [Related]
18. Hetero-Core-Shell BiNS-Fe@Fe as a Potential Theranostic Nanoplatform for Multimodal Imaging-Guided Simultaneous Photothermal-Photodynamic and Chemodynamic Treatment.
Ma S; Xie J; Wang L; Zhou Z; Luo X; Yan J; Ran G
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10728-10740. PubMed ID: 33645960
[TBL] [Abstract][Full Text] [Related]
19. All-in-One Theranostic Platforms: Deep-Red AIE Nanocrystals to Target Dual-Organelles for Efficient Photodynamic Therapy.
Xu R; Chi W; Zhao Y; Tang Y; Jing X; Wang Z; Zhou Y; Shen Q; Zhang J; Yang Z; Dang D; Meng L
ACS Nano; 2022 Dec; 16(12):20151-20162. PubMed ID: 36250626
[TBL] [Abstract][Full Text] [Related]
20. Rational engineering of semiconductor QDs enabling remarkable
Shen Y; Sun Y; Yan R; Chen E; Wang H; Ye D; Xu JJ; Chen HY
Biomaterials; 2017 Dec; 148():31-40. PubMed ID: 28961533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
